The broader market experienced mixed performance to start the week, with major indices showing volatility but ultimately closing higher. On Monday, Dow Jones Industrial Average (DJI) gained 0.78%. The...
The broader market experienced mixed performance on Monday, with major indices showing volatility but ultimately closing higher. The Dow Jones Industrial Average gained 0.78%. The S&P 500 rose 0.79%, and...
The company said that the official declaration of the cash dividend will be subject to the approval of Aerovate board of directors and is expected to be announced later this month.
AV-101 is being developed to address cellular hyperproliferation and resistance to apoptosis in the pulmonary vasculature, which are key features of the...
WALTHAM, Mass., May 16, 2022 (GLOBE NEWSWIRE) -- Aerovate Therapeutics, Inc. (Nasdaq: AVTE), a clinical stage biopharmaceutical company focused on...
Initiated IMPAHCT, a global Phase 2b/Phase 3 trial of AV-101 for pulmonary arterial hypertension (PAH) in December 2021Received FDA guidance in April 2021...